T2 Biosystems, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TTOO research report →
Companywww.t2biosystems.com
T2 Biosystems, Inc. , an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
- CEO
- Craig R. Jalbert
- IPO
- 2014
- Employees
- 113
- HQ
- Lexington, MA, US
Price Chart
Valuation
- Market Cap
- $84.14K
- P/E
- -0.00
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -0.77
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -113.58%
- Op Margin
- -690.45%
- Net Margin
- -696.19%
- ROE
- 147.27%
- ROIC
- -230.51%
Growth & Income
- Revenue
- $7.19M · -67.75%
- Net Income
- $-50,077,000 · 19.23%
- EPS
- $-19.19 · 98.43%
- Op Income
- $-49,664,000
- FCF YoY
- 5.18%
Performance & Tape
- 52W High
- $0.17
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 8.26
- Avg Volume
- 4.47K
Get TickerSpark's AI analysis on TTOO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 4, 24 | LIEBMAN SEYMOUR | other | 25,000 |
| Nov 4, 24 | Giffin Brett A. | other | 180,000 |
| Nov 4, 24 | Adams Laura Lee | other | 25,000 |
| Nov 4, 24 | CUMMING JOHN W | other | 35,000 |
| Nov 4, 24 | Gibbs Michael Terrence | other | 190,000 |
| Nov 4, 24 | Saunders Ninfa | other | 25,000 |
| Nov 4, 24 | Toft Robin | other | 25,000 |
| Nov 4, 24 | Sperzel John J III | other | 490,000 |
| Nov 4, 24 | Elsbree David B | other | 25,000 |
| Nov 4, 24 | Sprague John M | other | 180,000 |
Our TTOO Coverage
We haven't published any research on TTOO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TTOO Report →